Trinity Biotech Plc (TRIB) 23.90 $TRIB
Research and Markets: Global Rapid Medical Diagnostic Kits Trends and Forecasts, 2013 - 2019: Lateral Flow Technology, Agglutination Assays, Flow-through and Solid-phase Assays
Business Wire - Wed May 07, 6:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mcdlgw/rapid_medical) has announced the addition of the "Global Rapid Medical Diagnostic Kits Trends and Forecasts, 2013 - 2019: Lateral Flow Technology, Agglutination Assays, Flow-through and Solid-phase Assays" report to their offering.
Global Rapid Medical Diagnostic Kits Trends and Forecasts, 2013 - 2019: Lateral Flow Technology, Agglutination Assays, Flow-through and Solid-phase Assays
M2 - Wed May 07, 5:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lkpprc/rapid_medical) has announced the addition of the "Global Rapid Medical Diagnostic Kits Trends and Forecasts, 2013 - 2019: Lateral Flow Technology, Agglutination Assays, Flow-through and Solid-phase Assays" report to their offering. Some of the major players contributing to this market include Abbott Laboratories, Abaxis, Inc., Alere, Inc., Becton Dickinson & Company, BioRad Laboratories, F. Hoffmann La Roche, MegaCor, Trinity Biotech, Zoetis, Inc. Rapid medical diagnostics are tools for detection of various infectious diseases caused by virus and bacteria. Since the last decade remarkable prevalence of infectious diseases has been observed worldwide and its morbidity rate is rapidly growing. Increased detection of new pathogens-causing infections and increasing rate of weak immune system resulting from aging of population worldwide are some of the major factors leading to increase in the infectious diseases due to which the rapid medical diagnostic kits market is showing massive growth globally. Some other factors contributing to the growth of the rapid medical diagnostic kits market include cheaper cost of the rapid medical diagnostic kits, and increasing awareness about the available technologies for diagnosis of the infectious diseases caused by virus and bacteria. Rapid medical diagnostic kits market is mainly categorized on the basis of applications namely, clinical testing, home-use, infectious disease and veterinary and on the basis of technology used to develop rapid medical diagnostic platform namely, lateral flow technology, agglutination assays, flow-through and solid phase assays. The home-use rapid medical diagnostic application segment held the major market share of rapid medical diagnostic kits market in 2012 on account of the highly dominated blood glucose testing market. While on the technology side, lateral flow technology led the technology segment in the global rapid medical diagnostic kits market owing to presence of large number of approved rapid medical diagnostic kits with this technology. Moreover, its ease of use and quick turnaround time has been beneficial in malaria and pregnancy testing at home. The global rapid medical diagnostic kits market is highly fragmented in nature with many companies competing in the market. Well established market players dominate this market with their proprietary products and predatory growth strategies. Patent repository of the established market players is restraining growth and entry of the new market players entering into the market. Companies such as Millipore Corporation and Alere, Inc. are seeking patent approvals to secure their market share in the rapid medical diagnostic kits market. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Rapid Medical Diagnostic Kits Market Overview Chapter 4 Global Rapid Medical Diagnostic Kits Market, by Applications, 2011 - 2019 (USD Million) Chapter 5 Global Rapid Medical Diagnostic Kits Market, by Technology, 2011 - 2019 (USD Million) Chapter 6 Global Rapid Medical Diagnostic Kits Market, by Geography, 2011 - 2019, (USD Million) Chapter 7 Recommendations Chapter 8 Competitive Landscape Chapter 9 Company Profiles - Abaxis, Inc. - Abbott Laboratories, Inc. - Alere, Inc. - Becton, Dickinson & Company - Bio-Rad Laboratories, Inc. - Danaher Corporation (Beckman Coulter) - MegaCor Diagnostik GmbH - F. Hoffmann-La Roche Ltd. - Trinity Biotech plc - Zoetis, Inc. For more information visit http://www.researchandmarkets.com/research/lk...id_medical
Upgrade Alert for Trinity Biotech (TRIB)
Comtex SmarTrend(R) - Wed Apr 30, 7:08AM CDT
Trinity Biotech (NASDAQ:TRIB) was upgraded from Neutral to Buy at Roth Capital today. The stock closed yesterday at $24.70 on volume of 564,000 shares, above average daily volume of 97,000. Over the past year, Trinity Biotech has traded in a range of $15.57 to $28.06 and closed yesterday at $24.70, 59% above that low. Over the last five market days, the 200-day moving average (MA) has gone up 0.5% while the 50-day MA has declined 0.5%.
Trinity Biotech Announces Quarter 1 Results
GlobeNewswire - Tue Apr 29, 9:29AM CDT
Revenues Up 23%, Operating Profit Up 16%
3 Stocks Rising on Unusual Volume
at The Street - Tue Apr 29, 7:31AM CDT
Unusual volume can signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.
Global Enteric Disease Testing Market 2014-2018: Alere, bioMerieux, Bio-Rad Laboratories, Cepheid & DiaSorin Dominate the Market
M2 - Mon Apr 28, 11:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/s27mxj/global_enteric) has announced the addition of the "Global Enteric Disease Testing Market 2014-2018: Alere, bioM?rieux, Bio-Rad Laboratories, Cepheid & DiaSorin Dominate the Market" report to their offering. One of the major drivers in the market is the increasing incidence of enteric diseases among the population, creating a need for testing methods that effectively diagnose diseases. The discovery and characterization of new emerging viruses and bacteria is playing an important role in the Diagnostics industry. Vendors are introducing new diagnostic tests for new found pathogens that are responsible for some other types of infectious diseases. These new pathogens include West Nile virus, respiratory syncytial virus, genital mycoplasma, C. difficile, norovirus, and rotavirus. C. difficile and rotavirus tests have seen the maximum level of acceptance in the market. Thus, the improvement in detection technology aiding in the identification of new pathogens is driving the need for enteric disease testing products. Further, the report states that one of the major challenges in the market is the presence of stringent regulatory approval processes for clinical in-vitro diagnostic tests for enteric disease identification. Key vendors dominating this space are: - Alere Inc - bioM?rieux SA - Bio-Rad Laboratories Inc. - Cepheid Inc. - DiaSorin S.p.A. Other vendors mentioned in the report are: - Affymetrix Inc. - Beckton, Dickenson and Co - Biomerica Inc - Coris BioConcept - Danaher Corp. - Meridian Bioscience Inc. - Quest Diagnostics Inc. - R-Biopharm AG - Trinity Biotech PLC. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Type of Diseases - Types of Clinical Diagnostic Testing - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/s2...al_enteric
Trinity Biotech plc to Announce First Quarter Fiscal Year 2014 Financial Results
GlobeNewswire - Wed Apr 16, 7:43AM CDT
Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter fiscal year 2014 on Tuesday, April 29, 2014. The Company has scheduled a conference call for that same day, Tuesday, April 29, 2014 at 11:00am ET (4:00pm BST) to discuss the results of the quarter.
Hemoglobin A1c Monitoring (HbA1c Laboratory Testing, and HbA1c Point of Care Testing) Market - Global Strategic Overview 2014
M2 - Thu Apr 10, 9:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bxd8pr/hemoglobin_a1c) has announced the addition of the "Hemoglobin A1c Monitoring - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Hemoglobin A1c Monitoring in US$ Million by the following Test Types: HbA1c Laboratory Testing, and HbA1c Point of Care Testing. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 27 companies including many key and niche players such as - Abbott Laboratories (US) - ARKRAY, Inc. (Japan) - Axis-Shield plc (UK) - Bayer Healthcare Diabetes Care (US) - Beckman Coulter, Inc. (US) - Bio-Rad Laboratories Inc (US) - Diazyme Laboratories Inc. (US) - EKF Diagnostics Holdings Plc (UK) - HEMOCUE? AB (Sweden) - Infopia Co. Ltd. (South Korea) - Menarini Diagnostics Ltd. (UK) - Roche Diagnostics (Switzerland) - Siemens Healthcare Diagnostics (Germany) - Tosoh Bioscience, Inc (US) - Trinity Biotech plc (Ireland) Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Diabetes A Brief Profile Of The Disease 3. Product Overview 4. Product Approvals/Introductions 5. Recent Industry Activity 6. Focus On Select Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 27 (including Divisions/Subsidiaries 35) - The United States (14) - Canada (1) - Japan (3) - Europe (14) - Germany (3) - The United Kingdom (5) - Italy (1) - Rest of Europe (5) - Asia-Pacific (Excluding Japan) (3) For more information visit http://www.researchandmarkets.com/research/bx...globin_a1c
Trinity Biotech (TRIB) Falls: Stock Goes Down 5.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 25, 9:00AM CDT
Trinity Biotech saw a big move last session, this breaks the recent trend of the company, as the stock is now trading below the volatile price range
Rapid Medical Diagnostic Kits Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Wed Mar 12, 3:58AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mdgmns/rapid_medical) has announced the addition of the "Rapid Medical Diagnostic Kits Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The rapid medical diagnostic kits market is experiencing impressive growth globally because of the continuous increase in demand for preventive management of infectious diseases. Since its introduction, rapid medical diagnostic kits are becoming a vital part of the medical diagnostics industry and the scope of this market has been perpetually increasing in terms of detectable diseases and adoption by end users. This report studies the global market for rapid diagnostic kits through three major perspectives namely, application areas, technologies and geography. The application segment of this market has been further segmented into three sub-divisions namely clinical testing, home-use and veterinary diagnostics. In addition, the technology segment of rapid medical diagnostic kits market has been categorized into lateral flow, flow-through, agglutination assays and solid phase. Each of the above segments are analyzed on the basis of their market size (in terms of USD million) for the period 2011 to 2019. This also includes the forecast of the market segments in terms of CAGR (%) for the period 2013 - 2019, considering 2012 as the base year. Geographically, the rapid medical diagnostic kits market is categorized into four regions namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market revenues (for the period 2011 - 2019) and forecast (for the period 2013 - 2019) for each of these regions have been included in this report. The market overview section of the report demonstrates the qualitative analysis of the market dynamics of the global rapid medical diagnostic kits market and thus includes information about the drivers, restraints, opportunities, Porter's five forces model and market attractiveness analysis of this industry. Key Topics Covered: Introduction Executive Summary Rapid Medical Diagnostic Kits Market Overview Global Rapid Medical Diagnostic Kits Market, by Applications, 2011 - 2019 (USD Million) Global Rapid Medical Diagnostic Kits Market, by Technology, 2011 - 2019 (USD Million) Global Rapid Medical Diagnostic Kits Market, by Geography, 2011 - 2019, (USD Million) Recommendations Competitive Landscape Companies Mentioned - Abaxis, Inc. - Abbott Laboratories, Inc. - Alere, Inc. - Becton, Dickinson & Company - Bio-Rad Laboratories, Inc. - Danaher Corporation (Beckman Coulter) - MegaCor Diagnostik GmbH - F. Hoffmann-La Roche Ltd. - Trinity Biotech plc - Zoetis, Inc. For more information visit http://www.researchandmarkets.com/research/md...id_medical About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Trinity Biotech Announces Results for Q4 and Fiscal Year 2013
GlobeNewswire - Tue Mar 04, 8:32AM CST
Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for fiscal year 2013 and the quarter ended December 31, 2013.
Do Euro Zone Stocks Signal Euro Deflation?
at The Street - Thu Feb 20, 3:58PM CST
Mary-Lynn Cesar, Kapitall: The European Central Bank believes the euro zone will avoid deflation. Do sales ratios of euro zone stocks disagree? The [...]
Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2013 Financial Results
GlobeNewswire - Wed Feb 19, 7:07AM CST
Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter fiscal year 2013 on Tuesday, March 4, 2014. The Company has scheduled a conference call for that same day, Tuesday, March 4, 2014 at 11:00am ET (4:00pm GMT) to discuss the results of the quarter.
2014 Analysis of the World Coagulation Testing Market: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities
M2 - Mon Feb 10, 2:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/bwwmws/2014_analysis_of) has announced the addition of the "2014 Analysis of the World Coagulation Testing Market: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities" report to their offering. This new report from Venture Planning Group contains 650 pages, 150 tables and provides forecasts for 40 major procedures by country and market segment, as well as sales and market shares for reagent and instrument suppliers. The report is available by region, country, section, market segment and individual test: Regions: Global, Europe Countries: Belarus, Benelux, France, Germany, Italy, Japan, Kazakhstan, Spain, UK, Ukraine, USA Sections: Assays, Competitors, Instrumentation, Technologies Market Segments: Hospitals (France, Germany, Italy, Japan, Spain, UK, USA), Physician Offices/POC Tests: APTT, Alpha-2 Antiplasmin, Antithrombin III, D-Dimer, Fibrinogen, Heparin, Proteins C and S, PT, Thrombin Time Key Topics Covered: Introduction Worldwide Market and Technology Overview A. Major Routine and Special Coagulation Tests B. Instrumentation Review C. Major in Vitro Diagnostic Technologies and Their Potential Applications D. Worldwide Market Overview D. Market Size, Growth And Major Suppliers Companies Mentioned: - Abbott - ADI/American Diagnostic - Axis-Shield - Alere/Biosite/Inverness - Beckman Coulter - Becton Dickinson - Bio/Data Corporation - Chrono-Log - Corgenix Medical - Diagnostica Stago/Trinity Biotech - Helena Laboratories - HYPEN BioMed - Instrumentation Laboratory - ITC - Roche - Siemens - Sienco - Sysmex - Thermo Fischer - Trinity Biotech - ZyCare/Alere For more information visit http://www.researchandmarkets.com/research/bw...nalysis_of
Concise Analysis on the International Enteric Disease Testing Market - Forecasts to 2019
M2 - Wed Feb 05, 5:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/v3x48h/enteric_disease) has announced the addition of the "Concise Analysis on the International Enteric Disease Testing Market - Forecasts to 2019" report to their offering. Various microbes responsible for enteric infections include salmonella, shigella, rotavirus, norovirus, c. difficile, cryptosporidium, vibrio and campylobacter. These diseases may range from asymptomatic to having mild to severe symptoms such as bloody diarrhea, abdominal cramps, stool containing blood or pus, fever and weight loss. Incubation period varies from few days to few weeks depending on the disease and severity. In order to reduce the chance of developing complications, these diseases needed to be diagnosed early. Earlier, diagnosis of enteric diseases relied on culture results of stool specimen that involved identification of causative pathogens in a culture medium. However, the trend is now shifting from culture methods to other diagnostic methods owing to limitations associated with culture tests. Major drawbacks associated with culture tests include high cost, labor intensive, requires sophisticated laboratory and a skilled person to perform the diagnosis. On the other hand, enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR) has made enteric infection diagnosis easy and fast. In developed regions such as North America and Europe, PCR based diagnosis is most recommended testing method for enteric diseases as it offers high sensitivity and specificity and is considered as easy, accurate, rapid and reliable method of diagnosis. Latest introductions in MALDI-TOF have also been developed for rapid diagnosis of whole organisms without destruction of infection sample. Asia-Pacific accounting for more than 50% of the total global population represents the most profitable market for enteric disease testing in terms of growth and potential. Key Topics Covered: 1 Preface 2 Executive Summary 3 Enteric Disease Testing Market Overview 4 Global Enteric Disease Testing Market 5 Global Enteric Disease Testing Market, By Geography, 2011 - 2019 6 Key Player Analysis for Enteric Disease Testing Market, 2012 7 Company Profiles Companies Mentioned: - Alere - Becton Dickinson & Company - Biomerica - Biomerieux - Bio-Rad - Cepheid - Coris Bioconcept - Diasorin - Meridian Bioscience - Quest Diagnostics - Trinity Biotech For more information visit http://www.researchandmarkets.com/research/v3...ic_disease
Trinity Biotech Announces European Approval of Guideline Compliant, Point-of-Care, High Sensitivity Troponin I Product
GlobeNewswire - Wed Jan 29, 7:27AM CST
Trinity Biotech plc. (Nasdaq:TRIB) today announced it has obtained the CE mark (i.e. European approval) for its Meritas, high sensitivity Troponin I (hsTnI) product. With its unrivalled precision, it is now the only point-of-care product capable of meeting all of the guidelines stipulated by the world's leading cardiac organisations for detection of heart attacks.
2013 Report on the International High-Growth Diagnostic Testing Markets
M2 - Mon Jan 13, 7:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/3946g5/highgrowth) has announced the addition of the "2013 Report on the International High-Growth Diagnostic Testing Markets" report to their offering. Clinical labs experienced a substantial growth during the last decade. The emphasis in this report is on those companies that are actively developing and marketing high-growth diagnostic testing technologies in the clinical hospital market. It defines the dollar volume of sales, both worldwide and in the U.S., of the market and analyzes the factors that influence the size and growth of market segments. The study goes on to discuss in detail trends that have developed which have stimulated this market, and also comments in detail patterns of information processing in the high-growth diagnostic testing technologies. This examination provides an overview of the diagnostic testing market, including the latest information regarding exciting new products and industry trends. It will not only quantify but also qualify the market high-growth segments as an area of research and investment. Forecasts of the market and analyses of products in the worldwide prescriptions market will provide a basis for understanding the significance of past developments and future possibilities within this therapeutic category. Key Topics Covered: 1. Overview 2. Introduction to the High-Growth Testing Market 3. Hepatitis Serologic Markers and Nucleic Acid Testing 4. Human Papillomavirus (HPV) Testing 5. HIV 6. Infectious Disease Testing 7. Cardiac Markers 8. Cytogenetic Testing 9. Fertility Testing 10. Cancer Biomarker Testing 11. Substance Abuse Testing 12. Vitamin D Diagnostic Testing 13. Renal Dialysis Testing 14. Companion Diagnostics 15. Summary Analysis of the Global IVD High-Growth Market by Geographic Region 16. Clinical Laboratory Genomics 17. Cellular Imaging Cytopathology and Histopathology 18. High-Growth Testing Diagnostic Trends 19. Important Technology Trends 20. Molecular Diagnostics a Major Diagnostic Technological Advance 21. Technology Platform Innovations in POCT 22. Data Management and Connectivity 23. Biochips for Clinical Applications 24. Company Profiles Companies Mentioned: - A Menarini Diagnostics - Bayer Corporation - Calypte Biomedical Corporation - Denka Seiken - EY Laboratories - Enterix - Genetix - Genzyme Diagnostics - Hologic Gen Probe - Instrumentation Laboratory - Jiangnan Biotech - Johnson & Johnson - Kyowa Medex - LifeAssays AB - LifeScan - Matritech - NOVA Biomedical - OraSure - Pheromone Sciences Corporation - QIAGEN NV - Radiometer Medical - Roche Diagnostics - Shanghai SIIC Kehua Biotech - Shionogi & Co - Siemens Healthcare Diagnostics - Spectral Diagnostics - Trinity Biotech - V?samed - diaDexus For more information visit http://www.researchandmarkets.com/research/3946g5/highgrowth
AMAG Pharmaceuticals, Inc. to Present at the 32nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Thu Jan 09, 4:00PM CST
AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG), a specialty pharmaceutical company, announced today that William Heiden, AMAG's chief executive officer, will provide an update on the company followed by a breakout session at the 32 Annual J.P. Morgan Healthcare Conference on January 15, 2014 at 8:00 a.m. Pacific Time. During the presentation and breakout session, the company's business, regulatory status, strategy and growth prospects will be discussed.
Global Point of Care (PoC) Diagnostic Testing: World Market Report 2013
M2 - Tue Dec 17, 5:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/b8xvhg/point_of_care) has announced the addition of the "Global Point of Care (PoC) Diagnostic Testing: World Market Report 2013" report to their offering. Point of care testing covers: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening. "Global Point of Care (PoC) Diagnostic Testing: World Market Report 2013", describes latest developments in the point of care testing market segment. It examines clinical instruments, devices and reagents and supplies as utilized in near-patient environments like hospital emergency rooms, critical care units, clinics and doctor's offices. The study defines the dollar volume of point of care sales and makes five year projections both in the U.S. and worldwide - including Europe, Asia and Latin America. It also examines in detail the point of care sector for 25 individual country markets. Key Topics Covered: 1. Overview 2. Overview of Diagnostic Testing Point of Care Markets 3. Summary Analysis of the Global POCT Market: Value, Growth Rates and Market Share 4. Analysis of the U.S. POCT Market: Value, Growth Rates and Market Share 5. Analysis of the European POCT Market: Value, Growth Rates and Market Shares 6. Analysis of the POCT Markets for Japan, China and India: Value, Growth Rates and Market Share 7. Analysis of the Rest of World (ROW) POCT Market: Value, Growth Rates and Market Share 8. Review of the Market Segments, Reagents and Equipment 9. POCT: Growth Regulators 10. Business Trends in the POC Sector 11. Technology Platform Innovations in POCT 12. Data Management and Connectivity 13. Corporate Profiles 14. POCT Sector Trends and Forecasts 15. New Entrants to the Point of Care Market Companies Mentioned: - Axxin - Biosensia Ltd - Curetis AG - DxNA, LLC - Exalenz Bioscience - Guided Therapeutics, Inc - Home Diagnostics - International Technidyne Corporation - Johnson & Johnson - LifeSign, LLC - Mitsubishi Kagaku Iatron - Nova Biomedical - Orion Diagnostica - Prima Biomedical Company - Quidel Corporation - Roche Diagnostics - Strategic Diagnostics - Trinity Biotech, Plc - Venaxis, Inc - Wave 80 Biosciences For more information visit http://www.researchandmarkets.com/research/b8...nt_of_care
Uptrend Call Working As Trinity Biotech Stock Rises 17.1% (TRIB)
Comtex SmarTrend(R) - Fri Dec 06, 11:23AM CST
SmarTrend identified an Uptrend for Trinity Biotech (NASDAQ:TRIB) on September 20th, 2013 at $20.45. In approximately 3 months, Trinity Biotech has returned 17.11% as of today's recent price of $23.95.
Research and Markets: Global Rapid Medical Diagnostic Kits Trends and Forecasts, 2013 - 2019: Lateral Flow Technology, Agglutination Assays, Flow-through and Solid-phase Assays
Business Wire - Wed May 07, 6:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mcdlgw/rapid_medical) has announced the addition of the "Global Rapid Medical Diagnostic Kits Trends and Forecasts, 2013 - 2019: Lateral Flow Technology, Agglutination Assays, Flow-through and Solid-phase Assays" report to their offering.
Global Rapid Medical Diagnostic Kits Trends and Forecasts, 2013 - 2019: Lateral Flow Technology, Agglutination Assays, Flow-through and Solid-phase Assays
M2 - Wed May 07, 5:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lkpprc/rapid_medical) has announced the addition of the "Global Rapid Medical Diagnostic Kits Trends and Forecasts, 2013 - 2019: Lateral Flow Technology, Agglutination Assays, Flow-through and Solid-phase Assays" report to their offering. Some of the major players contributing to this market include Abbott Laboratories, Abaxis, Inc., Alere, Inc., Becton Dickinson & Company, BioRad Laboratories, F. Hoffmann La Roche, MegaCor, Trinity Biotech, Zoetis, Inc. Rapid medical diagnostics are tools for detection of various infectious diseases caused by virus and bacteria. Since the last decade remarkable prevalence of infectious diseases has been observed worldwide and its morbidity rate is rapidly growing. Increased detection of new pathogens-causing infections and increasing rate of weak immune system resulting from aging of population worldwide are some of the major factors leading to increase in the infectious diseases due to which the rapid medical diagnostic kits market is showing massive growth globally. Some other factors contributing to the growth of the rapid medical diagnostic kits market include cheaper cost of the rapid medical diagnostic kits, and increasing awareness about the available technologies for diagnosis of the infectious diseases caused by virus and bacteria. Rapid medical diagnostic kits market is mainly categorized on the basis of applications namely, clinical testing, home-use, infectious disease and veterinary and on the basis of technology used to develop rapid medical diagnostic platform namely, lateral flow technology, agglutination assays, flow-through and solid phase assays. The home-use rapid medical diagnostic application segment held the major market share of rapid medical diagnostic kits market in 2012 on account of the highly dominated blood glucose testing market. While on the technology side, lateral flow technology led the technology segment in the global rapid medical diagnostic kits market owing to presence of large number of approved rapid medical diagnostic kits with this technology. Moreover, its ease of use and quick turnaround time has been beneficial in malaria and pregnancy testing at home. The global rapid medical diagnostic kits market is highly fragmented in nature with many companies competing in the market. Well established market players dominate this market with their proprietary products and predatory growth strategies. Patent repository of the established market players is restraining growth and entry of the new market players entering into the market. Companies such as Millipore Corporation and Alere, Inc. are seeking patent approvals to secure their market share in the rapid medical diagnostic kits market. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Rapid Medical Diagnostic Kits Market Overview Chapter 4 Global Rapid Medical Diagnostic Kits Market, by Applications, 2011 - 2019 (USD Million) Chapter 5 Global Rapid Medical Diagnostic Kits Market, by Technology, 2011 - 2019 (USD Million) Chapter 6 Global Rapid Medical Diagnostic Kits Market, by Geography, 2011 - 2019, (USD Million) Chapter 7 Recommendations Chapter 8 Competitive Landscape Chapter 9 Company Profiles - Abaxis, Inc. - Abbott Laboratories, Inc. - Alere, Inc. - Becton, Dickinson & Company - Bio-Rad Laboratories, Inc. - Danaher Corporation (Beckman Coulter) - MegaCor Diagnostik GmbH - F. Hoffmann-La Roche Ltd. - Trinity Biotech plc - Zoetis, Inc. For more information visit http://www.researchandmarkets.com/research/lk...id_medical
Upgrade Alert for Trinity Biotech (TRIB)
Comtex SmarTrend(R) - Wed Apr 30, 7:08AM CDT
Trinity Biotech (NASDAQ:TRIB) was upgraded from Neutral to Buy at Roth Capital today. The stock closed yesterday at $24.70 on volume of 564,000 shares, above average daily volume of 97,000. Over the past year, Trinity Biotech has traded in a range of $15.57 to $28.06 and closed yesterday at $24.70, 59% above that low. Over the last five market days, the 200-day moving average (MA) has gone up 0.5% while the 50-day MA has declined 0.5%.
Trinity Biotech Announces Quarter 1 Results
GlobeNewswire - Tue Apr 29, 9:29AM CDT
Revenues Up 23%, Operating Profit Up 16%
3 Stocks Rising on Unusual Volume
at The Street - Tue Apr 29, 7:31AM CDT
Unusual volume can signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.
Global Enteric Disease Testing Market 2014-2018: Alere, bioMerieux, Bio-Rad Laboratories, Cepheid & DiaSorin Dominate the Market
M2 - Mon Apr 28, 11:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/s27mxj/global_enteric) has announced the addition of the "Global Enteric Disease Testing Market 2014-2018: Alere, bioM?rieux, Bio-Rad Laboratories, Cepheid & DiaSorin Dominate the Market" report to their offering. One of the major drivers in the market is the increasing incidence of enteric diseases among the population, creating a need for testing methods that effectively diagnose diseases. The discovery and characterization of new emerging viruses and bacteria is playing an important role in the Diagnostics industry. Vendors are introducing new diagnostic tests for new found pathogens that are responsible for some other types of infectious diseases. These new pathogens include West Nile virus, respiratory syncytial virus, genital mycoplasma, C. difficile, norovirus, and rotavirus. C. difficile and rotavirus tests have seen the maximum level of acceptance in the market. Thus, the improvement in detection technology aiding in the identification of new pathogens is driving the need for enteric disease testing products. Further, the report states that one of the major challenges in the market is the presence of stringent regulatory approval processes for clinical in-vitro diagnostic tests for enteric disease identification. Key vendors dominating this space are: - Alere Inc - bioM?rieux SA - Bio-Rad Laboratories Inc. - Cepheid Inc. - DiaSorin S.p.A. Other vendors mentioned in the report are: - Affymetrix Inc. - Beckton, Dickenson and Co - Biomerica Inc - Coris BioConcept - Danaher Corp. - Meridian Bioscience Inc. - Quest Diagnostics Inc. - R-Biopharm AG - Trinity Biotech PLC. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Type of Diseases - Types of Clinical Diagnostic Testing - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/s2...al_enteric
Trinity Biotech plc to Announce First Quarter Fiscal Year 2014 Financial Results
GlobeNewswire - Wed Apr 16, 7:43AM CDT
Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter fiscal year 2014 on Tuesday, April 29, 2014. The Company has scheduled a conference call for that same day, Tuesday, April 29, 2014 at 11:00am ET (4:00pm BST) to discuss the results of the quarter.
Hemoglobin A1c Monitoring (HbA1c Laboratory Testing, and HbA1c Point of Care Testing) Market - Global Strategic Overview 2014
M2 - Thu Apr 10, 9:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bxd8pr/hemoglobin_a1c) has announced the addition of the "Hemoglobin A1c Monitoring - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Hemoglobin A1c Monitoring in US$ Million by the following Test Types: HbA1c Laboratory Testing, and HbA1c Point of Care Testing. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 27 companies including many key and niche players such as - Abbott Laboratories (US) - ARKRAY, Inc. (Japan) - Axis-Shield plc (UK) - Bayer Healthcare Diabetes Care (US) - Beckman Coulter, Inc. (US) - Bio-Rad Laboratories Inc (US) - Diazyme Laboratories Inc. (US) - EKF Diagnostics Holdings Plc (UK) - HEMOCUE? AB (Sweden) - Infopia Co. Ltd. (South Korea) - Menarini Diagnostics Ltd. (UK) - Roche Diagnostics (Switzerland) - Siemens Healthcare Diagnostics (Germany) - Tosoh Bioscience, Inc (US) - Trinity Biotech plc (Ireland) Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Diabetes A Brief Profile Of The Disease 3. Product Overview 4. Product Approvals/Introductions 5. Recent Industry Activity 6. Focus On Select Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 27 (including Divisions/Subsidiaries 35) - The United States (14) - Canada (1) - Japan (3) - Europe (14) - Germany (3) - The United Kingdom (5) - Italy (1) - Rest of Europe (5) - Asia-Pacific (Excluding Japan) (3) For more information visit http://www.researchandmarkets.com/research/bx...globin_a1c
Trinity Biotech (TRIB) Falls: Stock Goes Down 5.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 25, 9:00AM CDT
Trinity Biotech saw a big move last session, this breaks the recent trend of the company, as the stock is now trading below the volatile price range
Rapid Medical Diagnostic Kits Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Wed Mar 12, 3:58AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mdgmns/rapid_medical) has announced the addition of the "Rapid Medical Diagnostic Kits Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The rapid medical diagnostic kits market is experiencing impressive growth globally because of the continuous increase in demand for preventive management of infectious diseases. Since its introduction, rapid medical diagnostic kits are becoming a vital part of the medical diagnostics industry and the scope of this market has been perpetually increasing in terms of detectable diseases and adoption by end users. This report studies the global market for rapid diagnostic kits through three major perspectives namely, application areas, technologies and geography. The application segment of this market has been further segmented into three sub-divisions namely clinical testing, home-use and veterinary diagnostics. In addition, the technology segment of rapid medical diagnostic kits market has been categorized into lateral flow, flow-through, agglutination assays and solid phase. Each of the above segments are analyzed on the basis of their market size (in terms of USD million) for the period 2011 to 2019. This also includes the forecast of the market segments in terms of CAGR (%) for the period 2013 - 2019, considering 2012 as the base year. Geographically, the rapid medical diagnostic kits market is categorized into four regions namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market revenues (for the period 2011 - 2019) and forecast (for the period 2013 - 2019) for each of these regions have been included in this report. The market overview section of the report demonstrates the qualitative analysis of the market dynamics of the global rapid medical diagnostic kits market and thus includes information about the drivers, restraints, opportunities, Porter's five forces model and market attractiveness analysis of this industry. Key Topics Covered: Introduction Executive Summary Rapid Medical Diagnostic Kits Market Overview Global Rapid Medical Diagnostic Kits Market, by Applications, 2011 - 2019 (USD Million) Global Rapid Medical Diagnostic Kits Market, by Technology, 2011 - 2019 (USD Million) Global Rapid Medical Diagnostic Kits Market, by Geography, 2011 - 2019, (USD Million) Recommendations Competitive Landscape Companies Mentioned - Abaxis, Inc. - Abbott Laboratories, Inc. - Alere, Inc. - Becton, Dickinson & Company - Bio-Rad Laboratories, Inc. - Danaher Corporation (Beckman Coulter) - MegaCor Diagnostik GmbH - F. Hoffmann-La Roche Ltd. - Trinity Biotech plc - Zoetis, Inc. For more information visit http://www.researchandmarkets.com/research/md...id_medical About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Trinity Biotech Announces Results for Q4 and Fiscal Year 2013
GlobeNewswire - Tue Mar 04, 8:32AM CST
Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for fiscal year 2013 and the quarter ended December 31, 2013.
Do Euro Zone Stocks Signal Euro Deflation?
at The Street - Thu Feb 20, 3:58PM CST
Mary-Lynn Cesar, Kapitall: The European Central Bank believes the euro zone will avoid deflation. Do sales ratios of euro zone stocks disagree? The [...]
Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2013 Financial Results
GlobeNewswire - Wed Feb 19, 7:07AM CST
Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter fiscal year 2013 on Tuesday, March 4, 2014. The Company has scheduled a conference call for that same day, Tuesday, March 4, 2014 at 11:00am ET (4:00pm GMT) to discuss the results of the quarter.
2014 Analysis of the World Coagulation Testing Market: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities
M2 - Mon Feb 10, 2:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/bwwmws/2014_analysis_of) has announced the addition of the "2014 Analysis of the World Coagulation Testing Market: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities" report to their offering. This new report from Venture Planning Group contains 650 pages, 150 tables and provides forecasts for 40 major procedures by country and market segment, as well as sales and market shares for reagent and instrument suppliers. The report is available by region, country, section, market segment and individual test: Regions: Global, Europe Countries: Belarus, Benelux, France, Germany, Italy, Japan, Kazakhstan, Spain, UK, Ukraine, USA Sections: Assays, Competitors, Instrumentation, Technologies Market Segments: Hospitals (France, Germany, Italy, Japan, Spain, UK, USA), Physician Offices/POC Tests: APTT, Alpha-2 Antiplasmin, Antithrombin III, D-Dimer, Fibrinogen, Heparin, Proteins C and S, PT, Thrombin Time Key Topics Covered: Introduction Worldwide Market and Technology Overview A. Major Routine and Special Coagulation Tests B. Instrumentation Review C. Major in Vitro Diagnostic Technologies and Their Potential Applications D. Worldwide Market Overview D. Market Size, Growth And Major Suppliers Companies Mentioned: - Abbott - ADI/American Diagnostic - Axis-Shield - Alere/Biosite/Inverness - Beckman Coulter - Becton Dickinson - Bio/Data Corporation - Chrono-Log - Corgenix Medical - Diagnostica Stago/Trinity Biotech - Helena Laboratories - HYPEN BioMed - Instrumentation Laboratory - ITC - Roche - Siemens - Sienco - Sysmex - Thermo Fischer - Trinity Biotech - ZyCare/Alere For more information visit http://www.researchandmarkets.com/research/bw...nalysis_of
Concise Analysis on the International Enteric Disease Testing Market - Forecasts to 2019
M2 - Wed Feb 05, 5:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/v3x48h/enteric_disease) has announced the addition of the "Concise Analysis on the International Enteric Disease Testing Market - Forecasts to 2019" report to their offering. Various microbes responsible for enteric infections include salmonella, shigella, rotavirus, norovirus, c. difficile, cryptosporidium, vibrio and campylobacter. These diseases may range from asymptomatic to having mild to severe symptoms such as bloody diarrhea, abdominal cramps, stool containing blood or pus, fever and weight loss. Incubation period varies from few days to few weeks depending on the disease and severity. In order to reduce the chance of developing complications, these diseases needed to be diagnosed early. Earlier, diagnosis of enteric diseases relied on culture results of stool specimen that involved identification of causative pathogens in a culture medium. However, the trend is now shifting from culture methods to other diagnostic methods owing to limitations associated with culture tests. Major drawbacks associated with culture tests include high cost, labor intensive, requires sophisticated laboratory and a skilled person to perform the diagnosis. On the other hand, enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR) has made enteric infection diagnosis easy and fast. In developed regions such as North America and Europe, PCR based diagnosis is most recommended testing method for enteric diseases as it offers high sensitivity and specificity and is considered as easy, accurate, rapid and reliable method of diagnosis. Latest introductions in MALDI-TOF have also been developed for rapid diagnosis of whole organisms without destruction of infection sample. Asia-Pacific accounting for more than 50% of the total global population represents the most profitable market for enteric disease testing in terms of growth and potential. Key Topics Covered: 1 Preface 2 Executive Summary 3 Enteric Disease Testing Market Overview 4 Global Enteric Disease Testing Market 5 Global Enteric Disease Testing Market, By Geography, 2011 - 2019 6 Key Player Analysis for Enteric Disease Testing Market, 2012 7 Company Profiles Companies Mentioned: - Alere - Becton Dickinson & Company - Biomerica - Biomerieux - Bio-Rad - Cepheid - Coris Bioconcept - Diasorin - Meridian Bioscience - Quest Diagnostics - Trinity Biotech For more information visit http://www.researchandmarkets.com/research/v3...ic_disease
Trinity Biotech Announces European Approval of Guideline Compliant, Point-of-Care, High Sensitivity Troponin I Product
GlobeNewswire - Wed Jan 29, 7:27AM CST
Trinity Biotech plc. (Nasdaq:TRIB) today announced it has obtained the CE mark (i.e. European approval) for its Meritas, high sensitivity Troponin I (hsTnI) product. With its unrivalled precision, it is now the only point-of-care product capable of meeting all of the guidelines stipulated by the world's leading cardiac organisations for detection of heart attacks.
2013 Report on the International High-Growth Diagnostic Testing Markets
M2 - Mon Jan 13, 7:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/3946g5/highgrowth) has announced the addition of the "2013 Report on the International High-Growth Diagnostic Testing Markets" report to their offering. Clinical labs experienced a substantial growth during the last decade. The emphasis in this report is on those companies that are actively developing and marketing high-growth diagnostic testing technologies in the clinical hospital market. It defines the dollar volume of sales, both worldwide and in the U.S., of the market and analyzes the factors that influence the size and growth of market segments. The study goes on to discuss in detail trends that have developed which have stimulated this market, and also comments in detail patterns of information processing in the high-growth diagnostic testing technologies. This examination provides an overview of the diagnostic testing market, including the latest information regarding exciting new products and industry trends. It will not only quantify but also qualify the market high-growth segments as an area of research and investment. Forecasts of the market and analyses of products in the worldwide prescriptions market will provide a basis for understanding the significance of past developments and future possibilities within this therapeutic category. Key Topics Covered: 1. Overview 2. Introduction to the High-Growth Testing Market 3. Hepatitis Serologic Markers and Nucleic Acid Testing 4. Human Papillomavirus (HPV) Testing 5. HIV 6. Infectious Disease Testing 7. Cardiac Markers 8. Cytogenetic Testing 9. Fertility Testing 10. Cancer Biomarker Testing 11. Substance Abuse Testing 12. Vitamin D Diagnostic Testing 13. Renal Dialysis Testing 14. Companion Diagnostics 15. Summary Analysis of the Global IVD High-Growth Market by Geographic Region 16. Clinical Laboratory Genomics 17. Cellular Imaging Cytopathology and Histopathology 18. High-Growth Testing Diagnostic Trends 19. Important Technology Trends 20. Molecular Diagnostics a Major Diagnostic Technological Advance 21. Technology Platform Innovations in POCT 22. Data Management and Connectivity 23. Biochips for Clinical Applications 24. Company Profiles Companies Mentioned: - A Menarini Diagnostics - Bayer Corporation - Calypte Biomedical Corporation - Denka Seiken - EY Laboratories - Enterix - Genetix - Genzyme Diagnostics - Hologic Gen Probe - Instrumentation Laboratory - Jiangnan Biotech - Johnson & Johnson - Kyowa Medex - LifeAssays AB - LifeScan - Matritech - NOVA Biomedical - OraSure - Pheromone Sciences Corporation - QIAGEN NV - Radiometer Medical - Roche Diagnostics - Shanghai SIIC Kehua Biotech - Shionogi & Co - Siemens Healthcare Diagnostics - Spectral Diagnostics - Trinity Biotech - V?samed - diaDexus For more information visit http://www.researchandmarkets.com/research/3946g5/highgrowth
AMAG Pharmaceuticals, Inc. to Present at the 32nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Thu Jan 09, 4:00PM CST
AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG), a specialty pharmaceutical company, announced today that William Heiden, AMAG's chief executive officer, will provide an update on the company followed by a breakout session at the 32 Annual J.P. Morgan Healthcare Conference on January 15, 2014 at 8:00 a.m. Pacific Time. During the presentation and breakout session, the company's business, regulatory status, strategy and growth prospects will be discussed.
Global Point of Care (PoC) Diagnostic Testing: World Market Report 2013
M2 - Tue Dec 17, 5:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/b8xvhg/point_of_care) has announced the addition of the "Global Point of Care (PoC) Diagnostic Testing: World Market Report 2013" report to their offering. Point of care testing covers: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening. "Global Point of Care (PoC) Diagnostic Testing: World Market Report 2013", describes latest developments in the point of care testing market segment. It examines clinical instruments, devices and reagents and supplies as utilized in near-patient environments like hospital emergency rooms, critical care units, clinics and doctor's offices. The study defines the dollar volume of point of care sales and makes five year projections both in the U.S. and worldwide - including Europe, Asia and Latin America. It also examines in detail the point of care sector for 25 individual country markets. Key Topics Covered: 1. Overview 2. Overview of Diagnostic Testing Point of Care Markets 3. Summary Analysis of the Global POCT Market: Value, Growth Rates and Market Share 4. Analysis of the U.S. POCT Market: Value, Growth Rates and Market Share 5. Analysis of the European POCT Market: Value, Growth Rates and Market Shares 6. Analysis of the POCT Markets for Japan, China and India: Value, Growth Rates and Market Share 7. Analysis of the Rest of World (ROW) POCT Market: Value, Growth Rates and Market Share 8. Review of the Market Segments, Reagents and Equipment 9. POCT: Growth Regulators 10. Business Trends in the POC Sector 11. Technology Platform Innovations in POCT 12. Data Management and Connectivity 13. Corporate Profiles 14. POCT Sector Trends and Forecasts 15. New Entrants to the Point of Care Market Companies Mentioned: - Axxin - Biosensia Ltd - Curetis AG - DxNA, LLC - Exalenz Bioscience - Guided Therapeutics, Inc - Home Diagnostics - International Technidyne Corporation - Johnson & Johnson - LifeSign, LLC - Mitsubishi Kagaku Iatron - Nova Biomedical - Orion Diagnostica - Prima Biomedical Company - Quidel Corporation - Roche Diagnostics - Strategic Diagnostics - Trinity Biotech, Plc - Venaxis, Inc - Wave 80 Biosciences For more information visit http://www.researchandmarkets.com/research/b8...nt_of_care
Uptrend Call Working As Trinity Biotech Stock Rises 17.1% (TRIB)
Comtex SmarTrend(R) - Fri Dec 06, 11:23AM CST
SmarTrend identified an Uptrend for Trinity Biotech (NASDAQ:TRIB) on September 20th, 2013 at $20.45. In approximately 3 months, Trinity Biotech has returned 17.11% as of today's recent price of $23.95.
